Literature DB >> 32550616

Infectious Coryza: Persistence, Genotyping, and Vaccine Testing.

R A Gallardo1, A P Da Silva2, S Egaña-Labrin2, S Stoute3, C Kern4, H Zhou4, G Cutler5, C Corsiglia6.   

Abstract

The reemergence of infectious coryza (IC) caused by Avibacterium paragallinarum (AP) as an acute and occasionally chronic respiratory disease in domestic poultry has caused severe losses in several U.S. states. The disease is also associated with decreased egg production in layers and increased condemnations from air sac infections in broilers. A series of applied experiments were performed to elucidate the persistence of AP in infected broiler flocks, to genotype AP strains isolated from field cases, and to evaluate commercial and autogenous vaccine protection in commercial and specific-pathogen-free (SPF) chickens. Experimental evaluation of environmental persistence suggests that AP did not persist more than 12 hr in a hypothetically contaminated environment. Additionally, other detected potential pathogens such as Gallibacterium anatis and infectious bronchitis virus caused mild respiratory signs in the exposed birds. The HMTp210 and HagA genes of four IC field strains were sequenced and compared with published sequences of HMTp210 and HagA. The HMTp210 phylogeny showed a marginally imperfect clustering of the sequences in genogroups A, B, and C. Although not definitive, this phylogeny provided evidence that the four field strains aligned with previously characterized serovar C strains. Moreover, the base pair homology of the four strains was 100% identical to serovar C reference strains (H-18 and Modesto). HagA phylogeny was unclear, but interestingly, the IC field strains were 100% homologous to C-1 strains reported from Mexico and Ecuador. Finally, vaccine protection studies in commercial hens indicate that clinical signs are induced by a combination of IC and other concomitant pathogens infecting commercial birds. Additionally, vaccine protection experiments performed in SPF hens indicated that protection provided by the two commercial vaccines tested provided a reduction in clinical signs and bacterial shedding after two applications.

Entities:  

Keywords:  Avibacterium paragallinarum; genotyping; infectious coryza; prevention; serotyping; vaccines

Mesh:

Substances:

Year:  2020        PMID: 32550616     DOI: 10.1637/0005-2086-64.2.157

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  4 in total

1.  Novel NAD-independent Avibacterium paragallinarum: Isolation, characterization and molecular identification in Iran.

Authors:  Sheida Beiranvand; Tohid Piri-Gharaghie; Behnaz Dehganzad; Faranak Khedmati; Fatemeh Jalali; Mahya AsadAlizadeh; Hassan Momtaz
Journal:  Vet Med Sci       Date:  2022-02-19

2.  Pathogenicity of Avibacterium paragallinarum Strains from Peru and the Selection of Candidate Strains for an Inactivated Vaccine.

Authors:  Melanie Caballero-Garcia; Alfredo Mendoza-Espinoza; Silvia Ascanio; Paula Chero; Rober Rojas; Yosef Daniel Huberman
Journal:  Vaccines (Basel)       Date:  2022-06-29

3.  The Protective Efficacy of an Inactivated Vaccine against Avibacterium paragallinarum Field Isolates.

Authors:  Mengjiao Guo; Donghui Liu; Hengli Xu; Hao Zhang; Yikun Jin; Huihui Tan; Yantao Wu; Xiaorong Zhang
Journal:  Vet Sci       Date:  2022-08-26

4.  Isolation, Serovar Identification, and Antimicrobial Susceptibility of Avibacteriumparagallinarum from Chickens in China from 2019 to 2020.

Authors:  Mengjiao Guo; Xiufang Chen; Hao Zhang; Donghui Liu; Yantao Wu; Xiaorong Zhang
Journal:  Vet Sci       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.